ONK Therapeutics Enters into a Research Agreement with NUI Galway to Support Optimization of its Dual-Targeted NK Cell Therapy against AML – BioSpace

Galway, Ireland and San Diego, USA, 17 May 2021 ONK Therapeutics Ltd, an innovative natural killer (NK) cell therapy company, today announced that it has entered into a research collaboration with the National University of Ireland,Galway(NUI Galway)which provides access to unique expertise in evaluating the cancer cell microenvironment in Acute Myeloid Leukaemia (AML) and targeting of AML stem cells in models mimicking the bone marrow microenvironment.The research will support the optimization of ONK Therapeutics dual-targeted NK cell therapy program, ONKT104, being developed for the treatment of AML. ONK Therapeutics will fund a year-long research program in the laboratory of Dr

Read more
Top 12 Disruptive Gene and Cell Therapy Technologies Announced – Tyler Morning Telegraph

Boston, MA, May 21, 2021 (GLOBE NEWSWIRE) -- Mass General Brigham today announced its selections for the sixth annual Disruptive Dozen, 12 emerging gene and cell therapy (GCT) technologies with the greatest potential to impact health care in the next few years. The technologies were featured as part of the World Medical Innovation Forum held virtually from Boston to examine GCTs potential to impact patient care including a range of diseases and health system opportunities

Read more
Global Microcarrier Market Projected to Observe Remarkable Growth during the Forecast Period from 2020 to 2027 – Exclusive Report [Pages-189] by…

The global microcarrier market is anticipated to observe remarkable growth over the forecast period, owing to the rising number of cancer patients across the globe. By type, the equipment sub-segment is estimated to witness strong growth by 2027. Regionally, the North America region is anticipated to dominate the overall industry in the projected timeframe

Read more
International Society for Stem Cell Research

2 March, 2021 Can Stem Cell Research Save Endangered Species? Many species are facing eradication as the Earth undergoes its sixth mass extinction. Human innovation and changes to behavior, however, can slow down this annihilation of species through conscious environmental preservation, and surprisingly, stem cell research

Read more
Biotech cos Tzar Labs and Epigeneres to launch early-detection cancer tests – Business Standard

Tzar Labs, a molecular diagnostic company, and Mumbai-based Epigeneres Biotechnology, have claimed a breakthrough with their RNA-marker based technology for early detection of cancer rooted in stem cell biology. The blood tests, which can help determine whether cancer is absent, imminent, or present and also detect the different stages of the disease; will be launched by the end of this year. Ashish Tripathi, founder and CEO of Tzar Labs, said that they are awaiting the regulatory approvals, and are building the first laboratory in Mumbai now.

Read more